Boston Scientific Corp (BSX)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 414,000 | 2,502,000 | 2,988,000 | 2,329,000 | 865,000 | 952,000 | 426,000 | 570,000 | 928,000 | 338,000 | 276,000 | 325,000 | 1,925,000 | 1,947,000 | 2,675,000 | 2,016,000 | 1,734,000 | 2,022,000 | 1,724,000 | 370,000 |
| Short-term investments | US$ in thousands | — | 117,000 | — | 1,730,000 | — | — | 4,000 | 4,000 | 4,000 | — | 4,000 | 7,000 | — | — | — | — | — | — | — | — |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 6,399,000 | 5,910,000 | 5,576,000 | 4,916,000 | 4,933,000 | 4,579,000 | 4,562,000 | 4,083,000 | 3,803,000 | 3,549,000 | 3,883,000 | 4,275,000 | 4,274,000 | 4,022,000 | 4,073,000 | 3,393,000 | 3,681,000 | 3,302,000 | 3,108,000 | 3,976,000 |
| Quick ratio | 0.06 | 0.44 | 0.54 | 0.83 | 0.18 | 0.21 | 0.09 | 0.14 | 0.25 | 0.10 | 0.07 | 0.08 | 0.45 | 0.48 | 0.66 | 0.59 | 0.47 | 0.61 | 0.55 | 0.09 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($414,000K
+ $—K
+ $—K)
÷ $6,399,000K
= 0.06
The quick ratio of Boston Scientific Corp has shown fluctuations over the period indicated. The quick ratio measures the company's ability to pay off its current liabilities with its most liquid assets. A higher quick ratio is generally considered better, as it indicates a stronger ability to cover short-term obligations.
From March 31, 2020, to September 30, 2021, the quick ratio generally improved, reaching its peak of 0.66 on June 30, 2021. This upward trend suggests that Boston Scientific Corp had a better ability to meet its short-term obligations during this period.
However, from March 31, 2022, to December 31, 2024, the quick ratio decreased significantly, hitting a low of 0.06 on December 31, 2024. This declining trend may indicate potential challenges in meeting short-term liabilities with liquid assets during this period.
It is important for stakeholders to monitor these fluctuations in the quick ratio to assess the company's liquidity position and ability to manage its short-term financial obligations effectively. Additional analysis and insight into the company's financial health may be required to understand the underlying factors driving these changes in the quick ratio.
Peer comparison
Dec 31, 2024